These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
321 related items for PubMed ID: 20970559
1. Renin-angiotensin system dual blockade using angiotensin receptor plus aliskiren decreases severe proteinuria in kidney transplant recipients. López V, Martin M, Cobelo C, Aranda P, Cabello M, Sola E, Gutierrez C, Burgos D, Martínez D, Hernandez D. Transplant Proc; 2010 Oct; 42(8):2883-5. PubMed ID: 20970559 [Abstract] [Full Text] [Related]
7. Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade? Gerc V, Buksa M, Loza V, Kulic M. Med Arh; 2009 Oct; 63(6):343-9. PubMed ID: 20380117 [Abstract] [Full Text] [Related]
8. Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation. Freiberger V, Amann K, Heemann U, Frank H. Transpl Int; 2009 Nov; 22(11):1110-3. PubMed ID: 19497068 [Abstract] [Full Text] [Related]
9. Aliskiren and dual therapy in type 2 diabetes mellitus. Ingelfinger JR. N Engl J Med; 2008 Jun 05; 358(23):2503-5. PubMed ID: 18525047 [No Abstract] [Full Text] [Related]
10. Dual blockade of the renin-angiotensin-aldosterone system: beyond the ACE inhibitor and angiotensin-II receptor blocker combination. Bomback AS, Toto R. Am J Hypertens; 2009 Oct 05; 22(10):1032-40. PubMed ID: 19661925 [Abstract] [Full Text] [Related]
13. Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity. Dalla Vestra M, Simioni N, Masiero A. Minerva Endocrinol; 2009 Dec 05; 34(4):333-8. PubMed ID: 20046162 [Abstract] [Full Text] [Related]